Ruijie Zhang1,2, Xiankai Huo2, Qian Wang2, Juntao Zhang3, Shaofeng Duan3, Quan Zhang4, Shicai Zhang5. 1. Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin, 300052, China. 2. Department of Radiology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, 253000, Shandong, China. 3. Precision Health Institution, GE Healthcare, Pudong new town, Shanghai, 210000, China. 4. Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin, 300052, China. quanzhang@tmu.edu.cn. 5. Department of Radiology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, 253000, Shandong, China. zscrad@126.com.
Abstract
PURPOSE: To explore the feasibility and performance of machine learning-based radiomics models in predicting thyroid transcription factor-1 (TTF-1) expression in non-small cell lung cancer (NSCLC). METHODS: A total of 227 NSCLC patients were included in this retrospective study and divided into the training set and test set with a ratio of 8:2 randomly. Lung tumors on CT images were semi-automatic segmented utilizing 3D Slicer. Radiomic features quantifying tumor intensity, shape, texture, and transformed wavelet were extracted using a Python toolkit. Variance threshold (VT), principal component analysis (PCA), and least absolute shrinkage selection operator (LASSO) were used to reduce features; logistic regression (LR), random forest (RF), and support vector machine (SVM) were used to develop classifier, respectively. The performance of the models was evaluated by areas under the curves (AUC) of receiver operating characteristic (ROC) curves. Different models were compared by the Delong test to determine the optimal algorithms. RESULTS: Total 1968 radiomic features were extracted from the lung tumors images, and then 13, 15, and 13 stable features were selected by VT, PCA, and LASSO, respectively. Each classifier could discriminate against the TTF-1-positive groups with average AUC ranging from 0.601 to 0.784 in the training set. Among the models, three models constructed by the LASSO method showed satisfactory performance in the test set with AUC ranging from 0.715 to 0.787. The Delong test showed no significant difference between the LASSO models (P > 0.05). CONCLUSION: Machine learning-based radiomics model could predict the expression of TTF-1 in NSCLC patients.
PURPOSE: To explore the feasibility and performance of machine learning-based radiomics models in predicting thyroid transcription factor-1 (TTF-1) expression in non-small cell lung cancer (NSCLC). METHODS: A total of 227 NSCLC patients were included in this retrospective study and divided into the training set and test set with a ratio of 8:2 randomly. Lung tumors on CT images were semi-automatic segmented utilizing 3D Slicer. Radiomic features quantifying tumor intensity, shape, texture, and transformed wavelet were extracted using a Python toolkit. Variance threshold (VT), principal component analysis (PCA), and least absolute shrinkage selection operator (LASSO) were used to reduce features; logistic regression (LR), random forest (RF), and support vector machine (SVM) were used to develop classifier, respectively. The performance of the models was evaluated by areas under the curves (AUC) of receiver operating characteristic (ROC) curves. Different models were compared by the Delong test to determine the optimal algorithms. RESULTS: Total 1968 radiomic features were extracted from the lung tumors images, and then 13, 15, and 13 stable features were selected by VT, PCA, and LASSO, respectively. Each classifier could discriminate against the TTF-1-positive groups with average AUC ranging from 0.601 to 0.784 in the training set. Among the models, three models constructed by the LASSO method showed satisfactory performance in the test set with AUC ranging from 0.715 to 0.787. The Delong test showed no significant difference between the LASSO models (P > 0.05). CONCLUSION: Machine learning-based radiomics model could predict the expression of TTF-1 in NSCLC patients.
Authors: Bjørn H Grønberg; Marius Lund-Iversen; Erik H Strøm; Odd Terje Brustugun; Helge Scott Journal: J Thorac Oncol Date: 2013-10 Impact factor: 15.609
Authors: Garry Choy; Omid Khalilzadeh; Mark Michalski; Synho Do; Anthony E Samir; Oleg S Pianykh; J Raymond Geis; Pari V Pandharipande; James A Brink; Keith J Dreyer Journal: Radiology Date: 2018-06-26 Impact factor: 11.105
Authors: Qianbiao Gu; Zhichao Feng; Xiaoli Hu; Mengtian Ma; Mwajuma Mustafa Jumbe; Haixiong Yan; Peng Liu; Pengfei Rong Journal: Zhong Nan Da Xue Xue Bao Yi Xue Ban Date: 2019-09-28
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396